Daniel H. Palmer

31.6k citations

219 papers · 11.7k indexed · 5 hit papers · h-index 39

Impact in

Hepatology top 0.1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers

Papers in

Hepatology 52
- Hepatocellular Carcinoma Treatment and Prognosis 51
Oncology 111
- Pancreatic and Hepatic Oncology Research 59
- Colorectal Cancer Treatments and Studies 24
- Cancer Immunotherapy and Biomarkers 17

Co-authors: Juan W. Valle David Cunningham Harpreet Wasan John Bridgewater Alan Anthoney Anthony Maraveyas Srinivasan Madhusudan Timothy Iveson
Journals: Journal of Clinical Oncology (58 papers)British Journal of Cancer (18 papers)Annals of Oncology (15 papers)Pancreatology (6 papers)European Journal of Surgical Oncology (5 papers)
Partner nations: United Kingdom Germany United States

In The Last Decade

Daniel H. Palmer

208 papers receiving 11.6k citations

Hit Papers

5 papers align trajectories log scale

Therapeutic developments in pancreatic cancer: current and future perspectives 2018 · 818 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Nature Reviews Gastroenterology & Hepatology
2017 The Lancet. Gastroenterology & hepatology
2016 Nature Cell Biology
2014 Journal of Clinical Oncology
2010 New England Journal of Medicine

Peers

Countries citing papers authored by Daniel H. Palmer

Since Specialization

Citations

This map shows the geographic impact of Daniel H. Palmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel H. Palmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel H. Palmer more than expected).

Fields of papers citing papers by Daniel H. Palmer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel H. Palmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel H. Palmer. The network helps show where Daniel H. Palmer may publish in the future.

Co-authors

The 25 scholars most cited alongside Daniel H. Palmer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel H. Palmer Line = papers co-authored together Daniel H. Palmer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Conserved biological processes in partial cellular reprogramming: Relevance to aging and rejuvenation Ageing Research Reviews ·Roberto A. Avelar, Daniel H. Palmer, Anton Kulaga, Georg Fuellen	2025	1
2	Cost-Effectiveness of Biomarker-Associated Early Pancreatic Cancer Detection in New-Onset Diabetes JAMA Network Open ·Irena Stefanova, Nathan E. Thompson, Lucy Oldfield, Martyn Stott, Robert N. Hanson, Daniel H. Palmer, Christopher Halloran, William Greenhalf, Robert Van Der Meer, Eithne Costello	2025	0
3	Reply to: Adjuvant Treatment Options and Modalities in Pancreatic Adenocarcinoma: Insights From ESPAC4 Journal of Clinical Oncology ·Daniel H. Palmer, Richard Jackson, Christoph Springfeld, Thilo Hackert, Christoph Michalski, John P. Neoptolemos	2025	0
4	Translanguaging at school: A systematic review of U.S. PK-12 translanguaging research System ·Laura Hamman‐Ortiz, Caitie Doughtery, Zhongfeng Tian, Daniel H. Palmer, Luis E. Poza	2025	4
5	Strawberry dietary intervention influences diversity and increases abundances of SCFA-producing bacteria in healthy elderly people Microbiology Spectrum ·Franziska Meiners, Bernd Kreikemeyer, Patrick Newels, Ingmar Zude, Michael Walter, A. Hartmann, Daniel H. Palmer, Georg Fuellen, Israel Barrantes	2025	2
6	Pembrolizumab (pembro) in patients (pts) with sorafenib-treated (cohort 1) and treatment (tx)-naive (cohort 2) advanced hepatocellular carcinoma (aHCC) after additional follow-up in the phase 2 KEYNOTE-224 study. Journal of Clinical Oncology ·Richard S. Finn, Masatoshi Kudo, Ivan Borbath, Julien Edeline, Stéphane Cattan, Hans Van Vlierberghe, Chris Verslype, Daniel H. Palmer, Per Stål, Sadahisa Ogasawara, Arndt Vogel, Mark Karwal, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Amos Odeleye-Ajakaye, Ken Hatogai, Abby B. Siegel, Ann‐Lii Cheng, Jean‐Luc Van Laethem	2024	2
7	Genomic profiling of idiopathic peri-hilar cholangiocarcinoma reveals new targets and mutational pathways Scientific Reports ·Leonard Quinn, Sam Haldenby, Philip Antzcak, Anna Fowler, Katie Bullock, John Kenny, Timothy Gilbert, Timothy Andrews, Rafael Díaz-Nieto, Stephen W. Fenwick, Robert Jones, Eithne Costello-Goldring, Graeme J. Poston, William Greenhalf, Daniel H. Palmer, Hassan Malik, Christopher E. Goldring	2023	5
8	In Vivo Tumorigenicity of the 20q11.21 Amplicon in an Engraftment Model of hPSCs and Differentiated Liver Cells PubMed ·Chris S. Pridgeon, Shiva S. Forootan, Fang Zhang, Nicholas W. Harper, Daniel H. Palmer, Richard Weightmann, Siân Gregory, Zoë Hewitt, Duncan Baker, Jason A. Halliwell, H. D. M. Moore, Emanuele Ricci, Peter W. Andrews, Harish Poptani, David C. Hay, B. Kevin Park, Christopher E. Goldring	2023	1
9	Healthy Aging in Times of Extreme Temperatures: Biomedical Approaches Aging and Disease ·Axel Kowald, Daniel H. Palmer, Riccardo Secci, Georg Fuellen	2023	2
10	1621P Efficacy and safety of erdafitinib in adults with pancreatic cancer and prespecified fibroblast growth factor receptor alterations (FGFRalt) in the phase II open-label: Single-arm RAGNAR trial Annals of Oncology ·Shubham Pant, Dirk Arnold, Josep Tabernero, Yohann Loriot, Gunnar Folprecht, Georg Martin Haag, Daniel H. Palmer, Hans Prenen, Jermaine Coward, Iwona Ługowska, J-C. Goeminne, Andrés Cervantes, Martin Gutierrez, Hussein Sweiti, Constance Hammond, S. Najmi, Shibu Thomas, Spyros Triantos, Lowell T. Crow, M.H.H. Schuler	2023	2
11	94MO Advanced extrahepatic cholangiocarcinoma: Post-hoc analysis of the ABC-01, -02 and -03 clinical trials Annals of Oncology ·Ángela Lamarca, Paul J. Ross, Harpreet Wasan, Richard Hubner, Mairéad G. McNamara, Andre Lopes, Daniel H. Palmer, Juan W. Valle, John Bridgewater	2023	1
12	Chemotherapy-induced infiltration of neutrophils promotes pancreatic cancer metastasis via Gas6/AXL signalling axis Gut ·Gaia Bellomo, Carolyn Rainer, Valeria Quaranta, Yuliana Astuti, Meirion Raymant, Elzbieta Boyd, Ruth Stafferton, Fiona Campbell, Paula Ghaneh, Christopher Halloran, Dean E. Hammond, Jennifer P. Morton, Daniel H. Palmer, Dale Vimalachandran, Robert Jones, Ainhoa Mielgo, Michael C. Schmid	2022	71
13	The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients: a randomised controlled trial (The EMPOWER Trial) SHILAP Revista de lepidopterología ·Lisa Loughney, Malcolm West, Helen Moyses, Andrew Bates, Graham J. Kemp, Lesley Hawkins, Judit Varkonyi-Sepp, Shaunna Burke, Christopher P. Barben, Peter M.A. Calverley, Trevor F. Cox, Daniel H. Palmer, Michael G. Mythen, Michael P. W. Grocott, Sandy Jack, (unknown)	2021	27
14	Towards biomarkers for outcomes after pancreatic ductal adenocarcinoma and ischaemic stroke, with focus on (co)-morbidity and ageing/cellular senescence (SASKit): protocol for a prospective cohort study BMJ Open ·Larissa Henze, Uwe Walter, Hugo Murua Escobar, Christian Junghanß, Robert Jaster, Rüdiger Köhling, Falko Lange, Ali Salehzadeh‐Yazdi, Olaf Wolkenhauer, Mohamed Hamed, Israel Barrantes, Daniel H. Palmer, Steffen Möller, Axel Kowald, N Heussen, Georg Fuellen	2020	3
15	A human tissue‐specific transcriptomic analysis reveals a complex relationship between aging, cancer, and cellular senescence Aging Cell ·Kasit Chatsirisupachai, Daniel H. Palmer, Susana Isabel Ferreira, João Pedro de Magalhães	2019	103
16	Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer Cancer Research ·Valeria Quaranta, Carolyn Rainer, Sebastian R. Nielsen, Meirion Raymant, Muhammad S. Ahmed, Dannielle D. Engle, Arthur Taylor, T. Murray, Fiona Campbell, Daniel H. Palmer, David A. Tuveson, Ainhoa Mielgo, Michael C. Schmid	2018	115
17	Proteomic profiling of rectal cancer reveals acid ceramidase is implicated in radiation response Journal of Proteomics ·David Bowden, Paul Sutton, Michael Wall, Puthen V. Jithesh, Rosalind E. Jenkins, Daniel H. Palmer, Christopher E. Goldring, Jason L. Parsons, B. K. Park, N.R. Kitteringham, Dale Vimalachandran	2018	19
18	PWE-135 Does Afp Predict Survival In Patients With Hepatocellular Carcinoma (hcc)? Gut ·F Yousuf, Wenyuan Ding, PD Richardson, Daniel H. Palmer, Imran Patanwala, TJ Cross	2014	3
19	Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom British Journal of Cancer ·Daniel H. Palmer, Syed A. Hussain, Anna Jo Bodurtha Smith, Sally Hargreaves, Yuk Ting, Diana Hull, P. J. Johnson, PJ Ross	2013	17
20	A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma† Hepatology ·Daniel H. Palmer, Rachel Midgley, Noweeda Mirza, Elizabeth Torr, Forhad Ahmed, Jane C. Steele, Neil Steven, Rachel Kerr, Lawrence S. Young, David Adams	2008	235

About Daniel H. Palmer

Daniel H. Palmer is a scholar working on Hepatology, Oncology, Cancer Research, Biotechnology and Pathology and Forensic Medicine, having authored 219 papers that have together received 11.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (59 papers), Hepatocellular Carcinoma Treatment and Prognosis (51 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (36 papers), Cancer Genomics and Diagnostics (27 papers), Colorectal Cancer Treatments and Studies (24 papers), Cancer Immunotherapy and Biomarkers (17 papers), Cancer Mechanisms and Therapy (16 papers) and Cancer Research and Treatments (16 papers). The work is most often cited by research in Hepatology (3.3k citations), Oncology (5.3k citations), Cancer Research (1.9k citations), Surgery (4.7k citations) and Pulmonary and Respiratory Medicine (3.0k citations). Daniel H. Palmer has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Juan W. Valle, David Cunningham, Harpreet Wasan, John Bridgewater, Alan Anthoney, Anthony Maraveyas, Srinivasan Madhusudan, Timothy Iveson, S. Hughes and Stephen P. Pereira. Their work appears in journals such as Journal of Clinical Oncology, British Journal of Cancer, Annals of Oncology, Pancreatology and European Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact